Phase 2 Futibatinib in Combination With PD-1 Antibody Based Standard of Care in Solid Tumors

Name: Phase 2 Futibatinib in Combination With PD-1 Antibody Based Standard of Care in Solid Tumors
License: Public Domain

Taiho Oncology, Inc.

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

pancreatic-cancer

locally advanced unresectable or metastatic solid tumors including esophageal cancer, esophageal adenocarcinoma, esophageal squamous cell cancer, siewert type 1 gej cancer, pancreatic cancer

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 195334
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.